ACR Appropriateness Criteria® on Incidentally Discovered Adrenal Mass1 1 The ACR Appropriateness Criteria® are evidence-based guidelines intended to guide referring physicians and other providers in making the most appropriate imaging or treatment decision for a given clinical condition. There are currently more than 160 clinical conditions, with over 700 variants

Journal of the American College of Radiology

Volumn 3, Issue 7, 2006, Pages 498-504

  Choyke, Peter L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adrenal mass; diagnostic imaging; incidentaloma

Indexed keywords

(3 IODOBENZYL)GUANIDINE; FLUORODEOXYGLUCOSE F 18; IODOCHOLESTEROL;

ABDOMINAL RADIOGRAPHY; ADRENAL BIOPSY; ADRENAL CANCER; ADRENAL CORTEX CARCINOMA; ADRENAL FUNCTION; ADRENAL TUMOR; ANAMNESIS; ARTICLE; BENIGN TUMOR; CANCER SIZE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CUSHING DISEASE; DIAGNOSTIC ACCURACY; ECHOGRAPHY; ENDOCRINE SURGERY; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PRIMARY HYPERALDOSTERONISM; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; X RAY;

EID: 84928096728     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacr.2006.02.031     Document Type: Article

References (43)

1. Gajraj H., and Young A.E. Adrenal incidentaloma. Br J Surg II 80 (1993) 422-426
2. Herrera M.F., Grant C.S., van Heerden J.A., Sheedy P.F., and Ilstrup D.M. Incidentally discovered adrenal tumors. an institutional perspective. Surgery 110 (1991) 1014-1021
3. Bernardino M.E., Walther M.M., Philips V.M., et al. CT-guided adrenal biopsy. accuracy, safety, and indications. Am J Roentgenol 144 (1985) 67-69
4. Francis I.R., Smid A., Gross M.D., Shapiro B., Naylor B., and Glazer G.M. Adrenal masses in oncologic patients. functional and morphologic evaluation. Radiology 166 (1988) 353-356
5. McGahan J.P. Adrenal gland. MR imaging. Radiology 166 (1988) 284-285
6. Candel A.G., Gattuso P., Reyes C.V., Prinz R.A., and Castelli M.J. Fine-needle aspiration biopsy of adrenal masses in patients with extraadrenal malignancy. Surgery 114 (1993) 1132-1136
7. Caplan R.H., Strutt P.J., and Wickus G.G. Subclinical hormone secretion by incidentally discovered adrenal masses. Arch Surg 129 (1994) 291-296
8. Lee M.J., Hahn P.F., Papanicolaou N., et al. Benign and malignant adrenal masses. CT distinction with attenuation coefficients, size and observer analysis. Radiology 179 (1991) 415-418
9. van Erkel A.R., van Gils A.P., Lequin M., Kruitwagen C., Bloem J.L., and Falke T.H. CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J Comput Assist Tomogr 18 (1994) 432-438
10. Reincke M., Nieke J., Krestin G.P., Saeger W., Allolio B., and Winkelmann W. Preclinical Cushing's syndrome in adrenal "incidentalomas". comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 75 (1992) 826-832
11. Bulow B., Ahren B., and Swedish Research Council Study Group of Endocrine Abdominal Tumours. Adrenal incidentaloma-experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252 (2002) 239-246
12. Singer A.A., Obuchowski N.A., Einstein D.M., and Paushter D.M. Metastasis or adenoma?. Computed tomographic evaluation of the adrenal mass. Cleve Clin J Med 61 (1994) 200-205
13. Stadler A., Schima W., Prager G., et al. CT density measurements for characterization of adrenal tumors ex vivo. variability among three CT scanners. Am J Roentgenol 182 (2004) 671-675
14. Bae K.T., Fuangtharnthip P., Prasad S.R., Joe B.N., and Heiken J.P. Adrenal masses. CT characterization with histogram analysis method. Radiology 228 (2003) 735-742
15. Korobkin M., Brodeur F.J., Francis I.R., Quint L.E., Dunnick N.R., and Londy F. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. Am J Roentgenol 170 (1998) 747-752
16. Korobkin M., and Francis I.R. Imaging of adrenal masses. Urol Clin North Am 24 (1997) 603-622
17. Szolar D.H., and Kammerhuber F.H. Adrenal adenomas and nonadenomas. assessment of washout at delayed contrast-enhanced CT. Radiology 207 (1998) 369-375
18. Choyke P.L. From needles to numbers. can noninvasive imaging distinguish benign and malignant adrenal lesions?. World J Urol 16 (1998) 29-34
19. Lee M.J., Mayo-Smith W.W., Hahn P.F., et al. State-of-the-art MR imaging of the adrenal gland. RadioGraphics 14 (1994) 1015-1029
20. Krestin G.P., Freidmann G., Fishbach R., Neufang K.F., and Allolio B. Evaluation of adrenal masses in oncologic patients. dynamic contrast-enhanced MR vs CT. J Comput Assist Tomogr 15 (1991) 104-110
21. Semelka R.C., Shoenut J.P., Lawrence P.H., et al. Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging. J Magn Reson Imaging 3 (1993) 337-343
22. Reinig J.W., Stutley J.E., Leonhardt C.M., Spicer K.M., Margolis M., and Caldwell C.B. Differentiation of adrenal masses with MR imaging. comparison of techniques. Radiology 192 (1994) 41-46
23. Leroy-Willig A., Bittoun J., Luton J.P., et al. In vivo MR spectroscopic imaging of the adrenal glands. distinction between adenomas and carcinomas larger than 15 mm based on lipid content. Am J Roentgenol 153 (1989) 771-773
24. Mitchell D.G., Crovello M., Matteucci T., Petersen R.O., and Miettinen M.M. Benign adrenocortical masses. diagnosis with chemical shift MR imaging. Radiology 185 (1992) 345-351
25. Tsushima Y., Ishizaka H., and Matsumoto M. Adrenal masses. differentiation with chemical shift, fast low-angle shot MR imaging. Radiology 186 (1993) 705-709
26. Mayo-Smith W.W., Lee M.J., McNicholas M.M., Hahn P.F., Boland G.W., and Saini S. Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging. observer performance versus quantitative measures. Am J Roentgenol 165 (1995) 91-95
27. Outwater E.K., Siegelman E.S., Radecki P.D., Piccoli C.W., and Mitchell D.G. Distinction between benign and malignant adrenal masses. value of T1-weighted chemical-shift MR Imaging. Am J Roentgenol 165 (1995) 579-583
28. McNicholas M.M., Lee M.J., Mayo-Smith W.W., Hahn P.F., Boland G.W., and Mueller P.R. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. Am J Roentgenol 165 (1995) 1453-1459
29. Fujiyoshi F., Nakajo M., Fukukura Y., and Tsuchimochi S. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging. comparison of four methods of quantitative evaluation. Am J Roentgenol 180 (2003) 1649-1657
30. Haider M.A., Ghai S., Jhaveri K., and Lockwood G. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses. does it still have a role?. Radiology 231 (2004) 711-716
31. Israel G.M., Korobkin M., Wang C., Hecht E.N., and Krinsky G.A. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. Am J Roentgenol 183 (2004) 215-219
32. Gabriel H., Pizzitola V., McComb E.N., Wiley E., and Miller F.H. Adrenal lesions with heterogeneous suppression on chemical shift imaging. clinical implications. J Magn Reson Imaging 19 (2004) 308-316
33. Tikkakoski T., Taavitsainen M., Paivansalo M., Lahde S., and Apaja-Sarkkinen M. Accuracy of adrenal biopsy guided by ultrasound and CT. Acta Radiol 32 (1991) 371-374
34. Silverman S.G., Mueller P.R., Pinkney L.P., Koenker R.M., and Seltzer S.E. Predictive value of image-guided adrenal biopsy. analysis of results of 101 biopsies. Radiology 187 (1993) 715-718
35. Wadih G.E., Nance K.V., and Silverman J.F. Fine-needle aspiration cytology of the adrenal gland. Fifty biopsies in 48 patients. Arch Pathol Lab Med 116 (1992) 841-846
36. Gillams A., Roberts C.M., Shaw P., Spiro S.G., and Goldstraw P. The value of CT scanning and percutaneous fine needle aspiration of adrenal masses in biopsy-proven lung cancer. Clin Radiol 46 (1992) 18-22
37. Lumachi F., Borsato S., Tregnaghi A., et al. CT-scan, MRI and image-guided FNA cytology of incidental adrenal masses. Eur J Surg Oncol 29 (2003) 689-692
38. Nakajo M., Nakabeppu Y., Yonekura R., Iwashita S., and Goto T. The role of adrenocortical scintigraphy in the evaluation of unilateral incidentally discovered adrenal and juxtaadrenal masses. Ann Nucl Med 7 (1993) 157-166
39. Hoh C.K., Schiepers C., Seltzer M.A., et al. PET in oncology. will it replace the other modalities?. Semin Nucl Med 27 (1997) 94-106
40. Kutlu C.A., Pastorino U., Maisey M., and Goldstraw P. Selective use of PET scan in the preoperative staging of NSCLC. Lung Cancer 21 (1998) 177-184
41. Erasmus J.J., Patz Jr. E.F., McAdams H.P., et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol 168 (1997) 1357-1360
42. Minn H., Salonen A., Friberg J., et al. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. J Nucl Med 45 (2004) 972-979
43. Zettinig G., Mitterhauser M., Wadsak W., et al. Positron emission tomography imaging of adrenal masses:(18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging 31 (2004) 1224-1230